Access to Medicine • January 30, 2025 Increasing Access to Innovative Medicines 2025 Ontario Budget… Learn more | View
Patented Medicine Prices Review Board (PMPRB) • January 04, 2024 IMC Response to the PMPRB’s 2023 Scoping Paper for the Consultations on the Board’s Guidelines Learn more | View
September 08, 2023 Submission on Consultation regarding Patent Term Adjustment (PTA) Regulations Learn more | View
Access to Medicine • August 21, 2023 IMC Response to the PMPRB’s 2023 Interim Guidance Consultation Learn more | View
June 08, 2023 Submission for the parliamentary consultations on Bill 15—An Act to Make the Health and Social Services more effective Learn more | View
Pharmacare • June 01, 2023 Addendum to Innovative Medicines Canada Submission on National Pharmacare Learn more | View
Patented Medicine Prices Review Board (PMPRB) • December 05, 2022 The Suspension and Reformulation of the PMPRB Guidelines is Urgently Required: IMC Response to PMPRB 2022 Guidelines Proposals Learn more | View
Patented Medicine Prices Review Board (PMPRB) • November 09, 2022 Letter to The Honourable Jean-Yves Duclos, P.C., M.P. Learn more | View
Patented Medicine Prices Review Board (PMPRB) • November 09, 2022 Letter to The Hon. Chrystia Freeland, P.C., M.P. Learn more | View
Patented Medicine Prices Review Board (PMPRB) • November 09, 2022 Letter to The Honourable Mary Ng, P.C., M.P. Learn more | View
Patented Medicine Prices Review Board (PMPRB) • November 09, 2022 Ministerial PMPRB Guideline Letter to The Hon. François-Philippe Champagne, P.C., M.P. Learn more | View